medigraphic.com
ISSN 1405-1710 (Print)

2015, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2015; 24 (1)

Melasma in men

Alcalá PD, Espinosa VN, Jurado SF

Language: Spanish
References: 22
Page: 14-20
PDF size: 224.73 Kb.


ABSTRACT

Melasma is a multifactorial acquired facial hipermelanosis that affects mostly women in their middle ages, 10% of all patients that are affected with this condition are men. The most important etiological factor that contributes to the onset of this disease is exposure to ultraviolet radiation. There is limited information about this condition in men, in which the quality of life is affected almost 1.5 times more than in men without dermatologic diseases. The purpose of this article is was to make a review of the etiology, pathophysiology, clinical manifestations and treatment of melasma in men as well as the impact in their quality of life.


REFERENCES

  1. Lakhdar H, Zouhair K, Essari A, Richard A, Seité S, Rougier A. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. JEADV. 2007; 21: 738-742.

  2. Zuluaga A, Fernández S, López MP, Builes AM, Manrique R et al. Factores de riesgo para el melasma. Med Cutan Iber Lat Am. 2007; 35: 178-184.

  3. Lonsdale-Eccles AA, Langtry JA. Melasma on the nape of the neck in a man. Acta Derm Venereol. 2005; 85: 181-182.

  4. Jang YH, Sim JH, Kang HY, Kim YC. The histopathological characteristics of male melasma: comparison with female melasma and lentigo. J Am Acad Dermatol. 2012; 66: 642-649.

  5. Pichardo R, Vallejos Q, Feldman SR, Schulz MR, Verma A, Quandt SA et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. International Journal of Dermatology. 2009; 48: 22-26.

  6. Vachiramon V, Suchonwanit P, Thadanipon K. Melasma in men. J Cosmetic Dermatol. 2012; 11: 151-157.

  7. Sarkar R, Puri P, Singh A, Desai A. Melasma in men: a clinical, aetiological and histological study. JEADV. 2010; 24: 768-772.

  8. Pandya A, Berneburg M, Ortonne JP, Picardo M. Guidelines for clinical trials in melasma. Br J Dermatol. 2006; 156 (Suppl 1): 21-28.

  9. Mercadillo PP, Moreno LLC. Fisiopatología del melasma. Dermatología CMQ. 2010; 8: 210-217.

  10. Cantú PP, Rodríguez O, Jurado F, Peralta ML. Niveles plasmáticos de hormona luteinizante (LH), hormona folículo estimulante (FSH), testosterona y estradiol en hombres con melasma versus sanos. UNAM [Tesis] 2006; pp. 53-74.

  11. Jadotte Y, Schwartz R. Melasma: insights and perspectives. Acta Dermatovenerol Croat. 2010; 18: 124-129.

  12. Porat K. Etiología, clínica y manejo del melasma. Revista Médica de Costa Rica y Centroamérica. 2011; 596: 57-60.

  13. Escutia-Muñoz B, Quecedo-Estébanez E, Botella-Estrada R. Tratamiento del melasma. Piel. 2010; 25: 405-410.

  14. Gupta A, Gover M, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006; 55: 1048-1065.

  15. Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A et al. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther (Heidelb). 2014; 4: 165-186.

  16. Sintim-Damoa A, Lambert WC, Schwartz R. Melasma: Insight into a distressing dyschromia. Aesthetic Dermatology. 2006; 8: 1-6.

  17. Sarkar R, Chugh S, Garg VK. Newer and upcoming therapies for melasma. Indian J Dermatol Venereol Leprol. 2012; 78: 417-428.

  18. Escutia B, Quecedo E, Botella R. Tratamiento del melasma. Piel. 2010; 25: 405-410.

  19. Ebrahimi B, Naeini FF. Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci. 2014; 19: 753-757.

  20. Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011; 2011: 379173.

  21. Kayamak Y, Önder M. An investigation of efficacy of topical niacinamide for the treatment of mild and moderate acne vulgaris. J Turk Acad Dermatol. 2008. www.jtad.org/2008/4/jtad82402a.pdf

  22. Jurado SCF, Villaseñor CGP, Peralta PML, Rodríguez AM, Morales SM. Calidad de vida en hombres con melasma. Rev Cent Dermatol Pascua. 2013; 22: 94-99.




2020     |     www.medigraphic.com